CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 366 filers reported holding CYTOKINETICS INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,035 | +36.3% | 92,933 | +76.5% | 0.03% | +21.4% |
| Q1 2024 | $3,693 | +1309.5% | 52,664 | +1580.4% | 0.03% | +1300.0% |
| Q4 2023 | $262 | -95.7% | 3,134 | -98.5% | 0.00% | -96.6% |
| Q3 2023 | $6,031 | -13.2% | 204,733 | -3.8% | 0.06% | +3.6% |
| Q2 2023 | $6,945 | -27.0% | 212,892 | -21.3% | 0.06% | -29.1% |
| Q1 2023 | $9,517 | +28.7% | 270,449 | +67.6% | 0.08% | -26.2% |
| Q4 2022 | $7,392 | -99.8% | 161,333 | +63.4% | 0.11% | +122.9% |
| Q2 2022 | $3,879,000 | +227.1% | 98,740 | +279.6% | 0.05% | +300.0% |
| Q4 2021 | $1,186,000 | -56.7% | 26,013 | -66.0% | 0.01% | -67.6% |
| Q3 2021 | $2,737,000 | +338.6% | 76,585 | +143.0% | 0.04% | +428.6% |
| Q2 2021 | $624,000 | -49.8% | 31,515 | -41.1% | 0.01% | -61.1% |
| Q1 2021 | $1,244,000 | +503.9% | 53,486 | +175.9% | 0.02% | +350.0% |
| Q4 2019 | $206,000 | – | 19,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
| Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
| WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
| PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
| Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
| Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |